Showing results (1301-1310 of 7,557) with videos related to

Sort By:
Pageof 756
Molecular Pharmaceutics|August 6, 2019
Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture TherapySinan Wang, Charles Blaha, Raquel Santos, et al.
Molecular Pharmaceutics|July 24, 2019
Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) ProteinsHong Shen, Ming Yao, Michael Sinz, et al.
Molecular Pharmaceutics|April 9, 2008
The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimersLisa M Kaminskas, Ben J Boyd, Peter Karellas, et al.
Molecular Pharmaceutics|May 22, 2008
Inhalable siRNA: potential as a therapeutic agent in the lungsNiamh Durcan, Charlotte Murphy, Sally-Ann Cryan
Molecular Pharmaceutics|March 15, 2008
Diversity of polyketide synthases found in the Aspergillus and Streptomyces genomesJames F Sanchez, Yi-Ming Chiang, Clay C C Wang
Molecular Pharmaceutics|May 9, 2008
Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNAHyun Ryoung Kim, In Kyoung Kim, Ki Hyun Bae, et al.
Molecular Pharmaceutics|May 9, 2008
Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide--doxorubicin conjugate in vitro and in vivoYuhong Ren, Yong Wang, Yufei Zhang, et al.
Molecular Pharmaceutics|April 17, 2014
The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalolMoran Zur, Marisa Gasparini, Omri Wolk, et al.
Molecular Pharmaceutics|April 17, 2014
A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapyQian Zhu, Lixin Jia, Zhongfei Gao, et al.
Molecular Pharmaceutics|April 18, 2014
Aptamer-targeted DNA nanostructures for therapeutic deliveryPhapanin Charoenphol, Harry Bermudez
Pageof 756